tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
BEAM
Beam Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Beam Therapeutics (BEAM) Stock News & Sentiment

Compare
1,399 Followers
Strategic Advantage and Exclusive Rights Bolster Beam Therapeutics’ Buy Rating
Premium
Ratings
Strategic Advantage and Exclusive Rights Bolster Beam Therapeutics’ Buy Rating
9h ago
BEAM
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
Premium
Weekend Updates
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
9d ago
U
BEAM
Promising BEAM-302 Trial Results and Strong Financial Position Support Buy Rating for Beam Therapeutics
Premium
Ratings
Promising BEAM-302 Trial Results and Strong Financial Position Support Buy Rating for Beam Therapeutics
12d ago
BEAM
Beam Therapeutics: Promising Phase 1 Results for BEAM-302 in AATD, Hold Rating Due to Long-term Efficacy Uncertainty
Premium
Ratings
Beam Therapeutics: Promising Phase 1 Results for BEAM-302 in AATD, Hold Rating Due to Long-term Efficacy Uncertainty
13d ago
BEAM
Promising Phase 1/2 Trial Results for Beam Therapeutics’ BEAM-302 Bolster Confidence and Support $80 Price Target
Premium
Ratings
Promising Phase 1/2 Trial Results for Beam Therapeutics’ BEAM-302 Bolster Confidence and Support $80 Price Target
14d ago
BEAM
Beam Therapeutics’ BEAM-302 Shows Promising Phase I/II Results, Earning Buy Rating from Analyst
Premium
Ratings
Beam Therapeutics’ BEAM-302 Shows Promising Phase I/II Results, Earning Buy Rating from Analyst
14d ago
BEAM
Beam Therapeutics’ BEAM-302 Shows Promising Efficacy and Safety in AATD Treatment, Earning Buy Rating
Premium
Ratings
Beam Therapeutics’ BEAM-302 Shows Promising Efficacy and Safety in AATD Treatment, Earning Buy Rating
14d ago
BEAM
More BEAM News >

BEAM News on the Web

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?
Zacks
Neutral
Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
TipRanks News
Neutral
Beam Therapeutics To Present At Barclays Global Healthcare Conference; Webcast At 3:30 PM ET
rttnews
Neutral
BEAM Down Despite Positive Initial Data From Genetic Disorder Study
Yahoo Finance
Neutral
Beam Therapeutics To Present At Leerink Partners Global Biopharma Conference; Webcast At 1:40 PM ET
rttnews
Neutral
Beam data 'encouraging,' support continuation of trial, says H.C. Wainwright
The Fly
Neutral
Is Beam Therapeutics Inc. the Best Emerging Technology Stock to Buy Now?
Yahoo Finance
Neutral
Beam Therapeutics Announces Pricing of Underwritten Offering
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
BEAM
Sector Average
Media Buzz
This Week1 articles
Weekly Average5 articles
News Sentiment
This Week50%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BEAM’s Media Buzz Sentiment?
1 articles about BEAM were published this week. In an average week, 5 articles are published.
    What is BEAM’s weekly average amount of articles?
    In an average week, 5 articles about BEAM are published.
      What is BEAM’s News Sentiment?
      50% of articles about BEAM were positive this week, compared to its sector average of 58%.
        Healthcare Stocks that are Trending in the News
        PLXProtalix
        DVAXDynavax
        OGNOrganon
        IMVTImmunovant
        RBOTVicarious Surgical
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing